Skip to main content
Clinical Trials/TCTR20231008001
TCTR20231008001
Completed
Phase 1

Comperative efficacy and safety of a microneedle patch for the improvement of the nasolabial fold : A split-face design double blind study

Thammasat University0 sites36 target enrollmentOctober 8, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Facial wrinkle in the nasolabial folds area
Sponsor
Thammasat University
Enrollment
36
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 8, 2023
End Date
August 25, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Female patient age between 20\-60 years old
  • 2\.Mild to moderate nasolabial folds according to the Merz Aesthetics Scale

Exclusion Criteria

  • 1\.Patient refuses to participate in the study
  • 2\.Pregnancy or lactation
  • 3\.History of energy base device treatment within 1 year
  • 4\.History of laser therapy within 6 months
  • 5\.History of chemical peeling within 1 month
  • 6\.History of mesotherapy injection at nasolabial folds within 1 month
  • 7\.History of Botox or filler injection at nasolabial folds within 1 year
  • 8\.History of taking antiplatelet and anticoagulants within 1 month
  • 9\.A current or prior history of infectious skin disease
  • 10\.A current or prior history of eczematous dermatitis on the face

Outcomes

Primary Outcomes

Not specified

Similar Trials